PROFID-EHRA Trial – ESC 2025 Update
PROFID-EHRA Trial – ESC 2025 Update
• Ongoing EU-funded trial testing if primary prevention ICDs are still needed post-MI with LVEF 35–50%.
• ~3,600 patients, 180 sites worldwide; recruitment started late 2023.
• Results expected 2027 — may redefine ICD use in ischemic cardiomyopathy.
• Jordan Cardiac Society (JCS) formally requested participation during its leadership meeting with ESC leaders in Madrid 2025, receiving strong interest and support.